Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 29 Neoplasms 12 Lung Neoplasms 11 Endometrial Neoplasms 11 Stomach Neoplasms 10 Lymphatic Metastasis 7 Head and Neck Neoplasms 7 Melanoma 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Sarcoma 3 Prostatic Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2 Margins of Excision 2 Giant Cell Tumor of Bone 2

Interventions

Sorafenib 61 Bevacizumab 42 Oxaliplatin 24 Doxorubicin 22 Radiosurgery 20 Gemcitabine 20 Fluorouracil 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 Capecitabine 17 lenvatinib 16 Cisplatin 16 atezolizumab 13 Leucovorin 13 Radiotherapy 11 tremelimumab 10 Cyclophosphamide 10 Carboplatin 10 Irinotecan 9 Ipilimumab 9 Drug Therapy 9 Everolimus 8 Cryosurgery 8 toripalimab 7 fludarabine 7 Sunitinib 7 Chemotherapy, Adjuvant 7 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Neoplasms × Indocyanine Green × Clear all

NCT05160740 2022-02-04

ICGMFITinPLC

Zhujiang Hospital

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡